Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

Skip to main content

Peer-to-peer education

Find links to third party education sites and view recorded
sessions from global RDN experts on the latest clinical data,
patient selection criteria and RDN procedure updates.

Connect with us
Alert Indications, Safety, and Warnings

Upcoming events

Check back regularly for updates on upcoming congresses and meetings.

Physician education sites

Expand All

Medscape education (CME credits available)

Medscape education

Clinical advances in interventional innovations for blood pressure control. 

Medscape’s education platform helps physicians learn about recent data with innovative interventional technology that can help patients achieve blood pressure control as an alternative to, or in addition to, typical treatment plans that include anti-hypertensive medications and lifestyle modifcations. CME credits available.

A laptop screen shows the RDN education homepage on the Medscape site.

How Much Blood Pressure Lowering Does It Take to Reduce CV Risk? The Answer May Surprise You

Listening to Patient Preferences to Overcome Poor Adherence: Is This the Key to Better BP Control?

Find Medscape courses

Radcliffe medical education (CME credits available)

WONDR Medical

American Heart Association (CME credits available)

American College of Cardiology (CME credits available)

A clipboard icon represents the availability of resources for patient selection.

Select the right patients

See which types of patients could beneft from the Symplicity blood pressure procedure.

Find criteria
An open book icon represents the breadth of clinical evidence for the Symplicity procedure.

Extensive clinical evidence

The Symplicity blood pressure procedure is supported by multiple clinical trials and a real-world patient registry.1-4

See the data
Illustration of kidneys.

Transforming hypertension treatment

The Symplicity blood pressure procedure is changing how patients with hypertension can reduce their blood pressure.

See the system
1

Mahfoud F, Kandzari DE, Kario K, et al. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial. The Lancet. 2022;399:1401-1410.

2

Mahfoud F, Mancia G, Schmieder R, et al. Three-year safety and efficacy in the Global Symplicity Registry: Impact of antihypertensive medication burden on blood pressure reduction. Presented at PCR e-course 2020.

3

Böhm M, Kario K, Kandzari DE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. The Lancet. 2020;395:1444-1451.

4

Kandzari DE, Böhm M, Mahfoud F, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. The Lancet. 2018;391(10137):2346.